Effects of dexmedetomidine on cesarean section patients: reducing intraoperative shivering and enhancing postoperative analgesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR1900002262

Enrollment

Unknown

Registered

2019-04-02

Start date

2019-04-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

Group D:Dexmedetomidine

Group C:normal saline

Eligibility

Sex/Gender

Female

Age

25 Years to 35 Years

Inclusion criteria

Inclusion criteria: Parturient is more than 37 weeks of single pregnancy; ASAI~II; Elective cesarean section; Aged 20 to 35 years; There was no history of mental illness or drug addiction.

Exclusion criteria

Exclusion criteria: Refuse intraspinal anesthesia or there are contraindications to intraspinal anesthesia; Refuse to participate in this study; Long-term use of antipsychotics; Having pregnancy complications or the fetus has intrauterine distress and other critical conditions.

Design outcomes

Primary

Measure	Time frame
The frequency of shivering;The frequency of visceral traction pain;VAS pain score;	—

Secondary

Measure	Time frame
vital signs;	—

Countries

China

Contacts

Public ContactYing Zhang

Department of Anesthesiology, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University

zhangying021210@163.com+86 13551720908

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026